Cite
Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
MLA
Islam, Kamrul, et al. “Anti-O-Specific Polysaccharide (OSP) Immune Responses Following Vaccination with Oral Cholera Vaccine CVD 103-HgR Correlate with Protection against Cholera after Infection with Wild-Type Vibrio Cholerae O1 El Tor Inaba in North American Volunteers.” PLoS Neglected Tropical Diseases, vol. 12, no. 4, Apr. 2018, pp. 1–19. EBSCOhost, https://doi.org/10.1371/journal.pntd.0006376.
APA
Islam, K., Hossain, M., Kelly, M., Mayo Smith, L. M., Charles, R. C., Bhuiyan, T. R., Kováč, P., Xu, P., LaRocque, R. C., Calderwood, S. B., Simon, J. K., Chen, W. H., Haney, D., Lock, M., Lyon, C. E., Kirkpatrick, B. D., Cohen, M., Levine, M. M., Gurwith, M., & Harris, J. B. (2018). Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. PLoS Neglected Tropical Diseases, 12(4), 1–19. https://doi.org/10.1371/journal.pntd.0006376
Chicago
Islam, Kamrul, Motaher Hossain, Meagan Kelly, Leslie M. Mayo Smith, Richelle C. Charles, Taufiqur Rahman Bhuiyan, Pavol Kováč, et al. 2018. “Anti-O-Specific Polysaccharide (OSP) Immune Responses Following Vaccination with Oral Cholera Vaccine CVD 103-HgR Correlate with Protection against Cholera after Infection with Wild-Type Vibrio Cholerae O1 El Tor Inaba in North American Volunteers.” PLoS Neglected Tropical Diseases 12 (4): 1–19. doi:10.1371/journal.pntd.0006376.